OUE Lippo Healthcare issues H2 2020 profit warning
Add BT as a preferred source
CATALIST-LISTED OUE Lippo Healthcare expects to post a "significant loss" in its half-year and full-year results, the board warned on Friday.
The group, which is scheduled to release its unaudited results by Feb 23, 2021, pointed to the impact of the Covid-19 pandemic on the period ended Dec 31, 2020.
OUE Lippo Healthcare expects provisions and impairments on the carrying value of its investments, including First Reit, which is planning a rights issue to avoid a debt default.
"Given the current pandemic situation and the fact that the group operates businesses and owns assets and has investments across several countries, there have been material repercussions on the financial performance of the group," the board said.
The group thus forecast a net loss for H2 2020 and FY2020 based on its preliminary assessment of its unaudited consolidated financial results.
The counter closed on Friday at S$0.035, up by 0.1 Singapore cent or 2.94 per cent, before the profit guidance was published.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
When every phone becomes a satellite phone, what happens to Asia’s telcos?
Singapore should anchor hedge fund leaders, nurture local managers amid regional talent war: observers
How BYD disrupted Singapore’s car market – and why the strategy is turning on itself
Too little, too late? Manila’s billion-dollar bid to ignite its sputtering EV industry
